We are live on ! Find out more
WA

Winfield Associates Portfolio holdings

AUM $276M
1-Year Est. Return 15.18%
This Fund
S&P 500
This Quarter Est. Return
+6.96%
1 Year Est. Return
+15.18%
3 Year Est. Return
+77.75%
5 Year Est. Return
+124.89%
10 Year Est. Return
AUM
$149M
AUM Growth
+$15.5M
Cap. Flow
+$7.39M
Cap. Flow %
4.95%
Top 10 Hldgs %
36.37%
Holding
334
New
26
Increased
75
Reduced
51
Closed
24

Sector Composition

Rank Sector Weight
1 Communication Services 8.95%
2 Consumer Discretionary 8.24%
3 Technology 8.09%
4 Financials 4.96%
5 Industrials 4.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TV icon
276
Televisa
TV
$1.47B
$4K ﹤0.01%
140
VTWO icon
277
Vanguard Russell 2000 ETF
VTWO
$17.5B
$4K ﹤0.01%
+90
New +$4.16K
WNC icon
278
Wabash National
WNC
$541M
$4K ﹤0.01%
300
ACG
279
DELISTED
AllianceBernstein Income Fund Inc
ACG
$4K ﹤0.01%
541
BAC icon
280
Bank of America
BAC
$439B
$3K ﹤0.01%
200
HII icon
281
Huntington Ingalls Industries
HII
$11.8B
$3K ﹤0.01%
25
IYW icon
282
iShares US Technology ETF
IYW
$23B
$3K ﹤0.01%
100
KMI icon
283
Kinder Morgan
KMI
$70.3B
$3K ﹤0.01%
200
-1,719
-90% -$41K
SBS icon
284
Sabesp
SBS
$19.4B
$3K ﹤0.01%
2,836
TNK icon
285
Teekay Tankers
TNK
$2.66B
$3K ﹤0.01%
50
BNY
286
Bank of New York Mellon
BNY
$106B
$2K ﹤0.01%
45
C icon
287
Citigroup
C
$222B
$2K ﹤0.01%
40
EXEL icon
288
Exelixis
EXEL
$14.2B
$2K ﹤0.01%
300
PAA icon
289
Plains All American Pipeline
PAA
$17.2B
$2K ﹤0.01%
100
PAAS icon
290
Pan American Silver
PAAS
$18.2B
$2K ﹤0.01%
300
VIRX
291
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$2K ﹤0.01%
11
SLCA
292
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$2K ﹤0.01%
100
STAB
293
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
$2K ﹤0.01%
500
-286
-36% -$1.15K
CPL
294
DELISTED
CPFL Energia S.A.
CPL
$2K ﹤0.01%
290
JHP
295
DELISTED
NUVEEN QUALITY PREFERRED INCOME FUND 3
JHP
$2K ﹤0.01%
229
AVNS icon
296
Avanos Medical
AVNS
$1K ﹤0.01%
+37
New +$1.15K
CLF icon
297
Cleveland-Cliffs
CLF
$6.84B
$1K ﹤0.01%
900
CP icon
298
Canadian Pacific Kansas City
CP
$81.4B
$1K ﹤0.01%
25
PBW icon
299
Invesco WilderHill Clean Energy ETF
PBW
$394M
$1K ﹤0.01%
40
NSLR
300
Neostellar Capital Corp
NSLR
$269M
$1K ﹤0.01%
154

Similar funds

Winfield Associates's Q4 2015 Portfolio in Review

As of Q4 2015, Winfield Associates held 334 positions worth $149M, up 12% from $134M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Winfield Associates deployed $7.39M of net new capital in Q4 2015, opening 26 new positions and adding to 75 existing holdings. Its largest new stake was Vertex Pharmaceuticals: 1,700 shares worth $214K.

By sector, the portfolio is most concentrated in Communication Services at 9% of assets, up from 8% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was State Street SPDR Bloomberg High Yield Bond ETF, an estimated $928K trimmed.

  • Winfield Associates's largest Q4 2015 buy was Vertex Pharmaceuticals: 1,700 shares worth $214K.
  • Winfield Associates added most to State Street SPDR S&P 500 ETF Trust in Q4 2015, an estimated $1.87M increase.
  • Winfield Associates's biggest Q4 2015 reduction was State Street SPDR Bloomberg High Yield Bond ETF, cutting an estimated $928K.
  • Winfield Associates fully exited CVR Refining, LP in Q4 2015, selling an estimated $333K.
  • Winfield Associates's ten largest holdings make up 36% of its $149M portfolio in Q4 2015.
  • Winfield Associates opened 26 new positions and closed 24 in Q4 2015.
  • Winfield Associates's portfolio value rose 12% quarter-over-quarter to $149M.

Based on Winfield Associates's 13F filing for Q4 2015, filed 17 Feb 2016.